osimertinib after surgery significantly improves survival in resected egfr-mutated nsclc
Published 1 year ago • 20 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:13
overall-survival analysis of adaura: osimertinib in resected egfrm stage ib-iiia nsclc
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
1:36
comment: front-line osimertinib significantly lengthens overall survival in egfr-mutation positi...
-
1:15
osimertinib improves survival in egfr nsclc, poses new challenges for resistance
-
5:06
front-line osimertinib significantly lengthens overall survival in egfr-mutation positive nsclc
-
6:30
osimertinib adjuvant therapy in patients with early stage egfr mutated nsclc after tumour resection
-
2:33
adaura: osimertinib adjuvant therapy in egfr mutated nsclc
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
3:19
adjuvant osimertinib in resected egfr-mutated nsclc
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
2:20
osimertinib with chemotherapy in egfr-mutated nsclc | nejm
-
5:26
first-line osimertinib in egfr mutant ansclc patients: progression pattern and safety in the rea...
-
2:21
osimertinib ipilimumab in egfr-mutated nsclc
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
1:23
flaura trial demonstrates efficacy in egfr-positive lung cancer
-
15:35
asco 2020: latest developments in egfr-mutated non-small cell lung cancer
-
8:06
adaura: osimertinib post-tumor resection in nsclc